These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 19787230)

  • 21. The in-vitro spheroid culture induces a more highly differentiated but tumorigenic population from melanoma cell lines.
    Mo J; Sun B; Zhao X; Gu Q; Dong X; Liu Z; Ma Y; Zhao N; Liu Y; Chi J; Sun R
    Melanoma Res; 2013 Aug; 23(4):254-63. PubMed ID: 23752306
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A rational approach for cancer stem-like cell isolation and characterization using CD44 and prominin-1(CD133) as selection markers.
    Lee YJ; Wu CC; Li JW; Ou CC; Hsu SC; Tseng HH; Kao MC; Liu JY
    Oncotarget; 2016 Nov; 7(48):78499-78515. PubMed ID: 27655682
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cancer stem cell traits in squamospheres derived from primary head and neck squamous cell carcinomas.
    Lim YC; Oh SY; Cha YY; Kim SH; Jin X; Kim H
    Oral Oncol; 2011 Feb; 47(2):83-91. PubMed ID: 21167769
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Enrichment and characterization of cancer stem‑like cells from a cervical cancer cell line.
    Wang L; Guo H; Lin C; Yang L; Wang X
    Mol Med Rep; 2014 Jun; 9(6):2117-23. PubMed ID: 24676900
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The CD133+ subpopulation of the SW982 human synovial sarcoma cell line exhibits cancer stem-like characteristics.
    Liu A; Feng B; Gu W; Cheng X; Tong T; Zhang H; Hu Y
    Int J Oncol; 2013 Apr; 42(4):1399-407. PubMed ID: 23416969
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Isolation and characterization of cancer stem cells from high-grade serous ovarian carcinomas.
    He QZ; Luo XZ; Wang K; Zhou Q; Ao H; Yang Y; Li SX; Li Y; Zhu HT; Duan T
    Cell Physiol Biochem; 2014; 33(1):173-84. PubMed ID: 24504111
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sphere culture of murine lung cancer cell lines are enriched with cancer initiating cells.
    Morrison BJ; Steel JC; Morris JC
    PLoS One; 2012; 7(11):e49752. PubMed ID: 23152931
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evidence for embryonic stem-like signature and epithelial-mesenchymal transition features in the spheroid cells derived from lung adenocarcinoma.
    Roudi R; Madjd Z; Ebrahimi M; Najafi A; Korourian A; Shariftabrizi A; Samadikuchaksaraei A
    Tumour Biol; 2016 Sep; 37(9):11843-11859. PubMed ID: 27048287
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Different Effects of BORIS/CTCFL on Stemness Gene Expression, Sphere Formation and Cell Survival in Epithelial Cancer Stem Cells.
    Alberti L; Losi L; Leyvraz S; Benhattar J
    PLoS One; 2015; 10(7):e0132977. PubMed ID: 26185996
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Melanoma spheroids grown under neural crest cell conditions are highly plastic migratory/invasive tumor cells endowed with immunomodulator function.
    Ramgolam K; Lauriol J; Lalou C; Lauden L; Michel L; de la Grange P; Khatib AM; Aoudjit F; Charron D; Alcaide-Loridan C; Al-Daccak R
    PLoS One; 2011 Apr; 6(4):e18784. PubMed ID: 21526207
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tumor initiating cells: development and critical characterization of a model derived from the A431 carcinoma cell line forming spheres in suspension.
    Bortolomai I; Canevari S; Facetti I; De Cecco L; Castellano G; Zacchetti A; Alison MR; Miotti S
    Cell Cycle; 2010 Mar; 9(6):1194-206. PubMed ID: 20237414
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sphere-forming stem-like cell populations with drug resistance in human sarcoma cell lines.
    Fujii H; Honoki K; Tsujiuchi T; Kido A; Yoshitani K; Takakura Y
    Int J Oncol; 2009 May; 34(5):1381-6. PubMed ID: 19360350
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Isolation and characterization of hepatic cancer cells with stem-like properties from hepatocellular carcinoma.
    Tomuleasa C; Soritau O; Rus-Ciuca D; Pop T; Todea D; Mosteanu O; Pintea B; Foris V; Susman S; Kacsó G; Irimie A
    J Gastrointestin Liver Dis; 2010 Mar; 19(1):61-7. PubMed ID: 20361077
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lgr5 promotes cancer stemness and confers chemoresistance through ABCB1 in colorectal cancer.
    Liu YS; Hsu HC; Tseng KC; Chen HC; Chen SJ
    Biomed Pharmacother; 2013 Oct; 67(8):791-9. PubMed ID: 24138824
    [TBL] [Abstract][Full Text] [Related]  

  • 35. CD133+ subpopulation of the HT1080 human fibrosarcoma cell line exhibits cancer stem-like characteristics.
    Feng BH; Liu AG; Gu WG; Deng L; Cheng XG; Tong TJ; Zhang HZ
    Oncol Rep; 2013 Aug; 30(2):815-23. PubMed ID: 23708735
    [TBL] [Abstract][Full Text] [Related]  

  • 36. PlGF Knockdown Decreases Tumorigenicity and Stemness Properties of Spheroid Body Cells Derived from Gastric Cancer Cells.
    Mahmoodi F; Akrami H
    J Cell Biochem; 2017 Apr; 118(4):851-859. PubMed ID: 27735991
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cancer stem-like cells can be isolated with drug selection in human ovarian cancer cell line SKOV3.
    Ma L; Lai D; Liu T; Cheng W; Guo L
    Acta Biochim Biophys Sin (Shanghai); 2010 Sep; 42(9):593-602. PubMed ID: 20705681
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Doxorubicin fails to eradicate cancer stem cells derived from anaplastic thyroid carcinoma cells: characterization of resistant cells.
    Zheng X; Cui D; Xu S; Brabant G; Derwahl M
    Int J Oncol; 2010 Aug; 37(2):307-15. PubMed ID: 20596658
    [TBL] [Abstract][Full Text] [Related]  

  • 39. LGR5 promotes cancer stem cell traits and chemoresistance in cervical cancer.
    Cao HZ; Liu XF; Yang WT; Chen Q; Zheng PS
    Cell Death Dis; 2017 Sep; 8(9):e3039. PubMed ID: 28880275
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Characterization of cervical cancer stem cell-like cells: phenotyping, stemness, and human papilloma virus co-receptor expression.
    Ortiz-Sánchez E; Santiago-López L; Cruz-Domínguez VB; Toledo-Guzmán ME; Hernández-Cueto D; Muñiz-Hernández S; Garrido E; Cantú De León D; García-Carrancá A
    Oncotarget; 2016 May; 7(22):31943-54. PubMed ID: 27008711
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.